Search results for "boosted"

showing 7 items of 7 documents

ATLAS measurements of the properties of jets for boosted particle searches

2012

Measurements are presented of the properties of high transverse momentum jets, produced in proton-proton collisions at a center-of-mass energy of √s=7  TeV. The data correspond to an integrated luminosity of 35  pb−1 and were collected with the ATLAS detector in 2010. Jet mass, width, eccentricity, planar flow and angularity are measured for jets reconstructed using the anti-kt algorithm with distance parameters R=0.6 and 1.0, with transverse momentum pT>300  GeV and pseudorapidity |η|<2. The measurements are compared to the expectations of Monte Carlo generators that match leading-logarithmic parton showers to leading-order, or next-to-leading-order, matrix elements. The generators describ…

Atlas detectorMonte Carlo methodParton7. Clean energy01 natural sciencesNucleonHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear ExperimentNUCLEONATLAS; jets; boostedQCDetectors de radiacióQuantum chromodynamicsPhysicsLarge Hadron ColliderAcceleradors de partículesSettore FIS/01 - Fisica SperimentaleATLASINCLUSIVE JET CROSS SECTIONLarge Hadron ColliderPseudorapidityTransverse momentumComputingMethodologies_DOCUMENTANDTEXTPROCESSINGLHCFRAGMENTATIONNucleonParticle Physics - ExperimentjetsNuclear and High Energy PhysicsParticle physicsCiências Naturais::Ciências Físicas530 PhysicsAstrophysics::High Energy Astrophysical Phenomena:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Partícules (Física nuclear)Proton-proton collisionsNuclear physics0103 physical sciencesddc:530High Energy Physics010306 general physicsCiencias ExactasScience & TechnologyATLAS detector010308 nuclear & particles physicsFísicaMODELHADRON-HADRON COLLISIONSCol·lisions (Física nuclear)PARTON DISTRIBUTIONSExperimental High Energy PhysicsHigh Energy Physics::ExperimentModel
researchProduct

Prediction of BOD5 content of the inflow to the treatment plant using different methods of black box - the case study

2020

The publication presents the possibility of modeling in a 1 d advance of the content of organic compounds in the influent wastewater to the treatment plant, where the content of these compounds is determined by both the biochemical and chemical oxygen demand. To predict the quality of the wastewater at the inflow a set of indicators where used to make measurements on a daily basis. In order to develop statistical models 3 methods where used, namely: multivariate adaptive regression splines (MARS), boosted trees (BT), and genetic programming (GP). The carried-out calculations showed that, to calculate the BOD5 there can only be used models developed on the basis of the value of daily wastewa…

HydrologyBoosted treesWastewater treatment plant (WWTP)Black boxOrganic compoundsBOD5Content (measure theory)Environmental scienceMultivariate adaptive regression splinesInflowCODGenetic programmingDESALINATION AND WATER TREATMENT
researchProduct

Low Rate of Virological Failure and Maintenance of Susceptibility to HIV-1 Protease Inhibitors with First-Line Lopinavir/Ritonavir-Based Antiretrovir…

2010

Protease inhibitor (PI)-resistant HIV-1 has hardly ever been detected at failed boosted PI-based first-line antiretroviral regimens in clinical trials. However, this phenomenon has not been investigated in clinical practice. To address this gap, data from patients starting a first-line lopinavir/ritonavir (LPV/rtv)-based therapy with available baseline HIV-1 RNA load, a viral genotype and follow-up viral load after 3 and 6 months of treatment were extracted from the Italian Antiretroviral Resistance Cohort Analysis (ARCA) observational database. Based on survival analysis, 39 (7.1%) and 43 (7.8%) of the 548 examined patient cases had an HIV-1 RNA >500 and >50 copies/ml, respectively, after …

MaleLopinavir/ritonavirHIV Infectionsboosted protease inhibitorLopinavirCohort Studies0302 clinical medicineAntiretroviral Therapy Highly Activevirologic failureHIV InfectionTreatment Failure030212 general & internal medicinePyrimidinone0303 health scienceseducation.field_of_studylopinavir/ritonavirLopinavirViral LoadResistance mutationfirst-line antiretroviral therapyReverse Transcriptase Inhibitor3. Good healthTreatment OutcomeInfectious DiseasesRNA ViralReverse Transcriptase InhibitorsMedicineDrug Therapy CombinationFemaleSurvival AnalysiViral loadHumanmedicine.drugAnti-HIV AgentsPopulationPyrimidinones.Settore MED/17 - MALATTIE INFETTIVEEmtricitabinehuman immunodeficiency virus type 103 medical and health sciencesVirologyDrug Resistance Viralantiretroviral drug resistancemedicineHumansProtease inhibitor (pharmacology)educationHIV Protease InhibitorRitonavir030306 microbiologybusiness.industryAnti-HIV AgentHIV Protease InhibitorsSurvival AnalysisVirologyHIV-1RitonavirCohort Studiebusiness
researchProduct

Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis.

2012

Introduction: This study aimed at defining protease (PR) resistance mutations associated with darunavir (DRV) failure and PR resistance evolution at DRV failure in a large database of treatment-experienced human immunodeficiency virus (HIV) patients. Results: Overall, 1,104 patients were included: 118 (10.7%) failed at a median observation time of 16 months. The mean number of PR mutations at baseline was 2.7, but it was higher in patients who subsequently failed DRV. In addition, the number of PR mutations increased at failure. The increase in the mean number of mutations was completely related to mutations considered to be associated with DRV resistance following the indications of the ma…

MaleTime FactorsCross-sectional studyHuman immunodeficiency virus (HIV)Drug ResistanceHIV InfectionsDrug resistancemedicine.disease_causeCohort StudiesAntiretroviral Therapy Highly ActiveRitonavir-boosted darunavirGenotypeHIV InfectionTreatment FailureViralGenotypic resistanceDarunavirSulfonamidesGeneral MedicineMiddle AgedVirological failureInfectious DiseasesFemaleHumanmedicine.drugAdultMicrobiology (medical)Logistic ModelTime FactorGenotypeAntiretroviral TherapySettore MED/17 - MALATTIE INFETTIVESulfonamideDrug Resistance ViralmedicineHumansHighly ActiveDarunavir; Genotypic resistance; Protease inhibitors; Ritonavir-boosted darunavir; Adult; Antiretroviral Therapy Highly Active; Cohort Studies; Cross-Sectional Studies; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Logistic Models; Male; Middle Aged; Mutation; Sulfonamides; Time Factors; Treatment Failure; Drug Resistance Viral; Microbiology (medical); Infectious DiseasesHIV Protease InhibitorDarunavirCross-Sectional Studiebusiness.industryHIV Protease InhibitorsProtease inhibitorsAntiretroviral therapyVirologyCross-Sectional StudiesLogistic ModelsProtease inhibitorMutationGenotypic resistanceHIV-1Cohort Studiebusiness
researchProduct

Predicting and mapping human risk of exposure to

2019

Background Tick-borne diseases have become increasingly common in recent decades and present a health problem in many parts of Europe. Control and prevention of these diseases require a better understanding of vector distribution. Aim Our aim was to create a model able to predict the distribution of Ixodes ricinus nymphs in southern Scandinavia and to assess how this relates to risk of human exposure. Methods We measured the presence of I. ricinus tick nymphs at 159 stratified random lowland forest and meadow sites in Denmark, Norway and Sweden by dragging 400 m transects from August to September 2016, representing a total distance of 63.6 km. Using climate and remote sensing environmental …

Nymphexposure riskClimateDenmarkPopulation DynamicsIxodes ricinustick-borne diseaseboosted regression treesEnvironmentScandinavian and Nordic CountriesModels Biologicalenvironmental satellite dataparasitic diseasesAnimalsHumansSwedenLyme DiseaseGeographyIxodesNorwayResearchhuman population densitypublic healthEnvironmental ExposureTick InfestationsPhylogeographyRemote Sensing TechnologySeasonsEncephalitis Tick-Bornenorthern EuropeEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
researchProduct

A method for approximating optimal statistical significances with machine-learned likelihoods

2022

The European physical journal / C 82(11), 993 (2022). doi:10.1140/epjc/s10052-022-10944-3

Physics and Astronomy (miscellaneous)Gluonsboosted particleFOS: Physical sciencesTop Quark530High Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)statistical analysisddc:530numerical calculationsEngineering (miscellaneous)Monte CarloInstrumentation and Methods for Astrophysics (astro-ph.IM)new physicsFísicadijet: final statefinal state [dijet]sensitivityHigh Energy Physics - Phenomenologymachine learningCERN LHC CollPhysics - Data Analysis Statistics and ProbabilitySubstructureAstrophysics - Instrumentation and Methods for AstrophysicsData Analysis Statistics and Probability (physics.data-an)
researchProduct

First measurement of the charge asymmetry in boosted top quark pair production in the ATLAS experiment using the Grid-based Tier-3 facility at IFIC-V…

2016

The Large Hadron Collider (LHC) at CERN is the largest collider ever built. It is assembled in the same 27 km tunnel where Large Electron-Positron Collider (LEP) used to be, $\sim$ 100 m underground, near Geneva (Switzerland). The main interaction points have four experiments installed: ATLAS, CMS, ALICE and LHCb. The LHC is designed to collide two proton beams, that circulate in opposite directions, each with an energy of up to 7 TeV, reaching a centre-of-mass energy up to 14 TeV. %%%%%%%%% The ATLAS experiment is a general-purpose detector designed to exploit the potential of the LHC. With a total weight of 7000 tonnes, ATLAS is the heaviest experiment at the LHC. It has 42 m of total len…

TierresonancesHigh Energy Physics::Phenomenologycharge asymmetryFísicaHigh Energy Physics::ExperimentboostedLHCATLASgridAltas energíastop quark
researchProduct